Kalaris Therapeutics, Inc. (KLRS)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 2 signals for Kalaris Therapeutics, Inc.. Most notable: 2026-07-06: Filed 8-K disclosing director or officer change; 2026-07-20: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider purchaseAKKARAJU SRINIVAS; Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC; Samsara Opportunity Fund, L.P.; Samsara Opportunity Fund GP, LLC (director) bought $1.2M of stock
- Insider purchaseSamsara BioCapital, L.P. (ten_percent_owner) bought $1.2M of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider purchaseSamsara Opportunity Fund, L.P. (ten_percent_owner) bought $5.0M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | Samsara BioCapital, L.P. | ten percent owner | J | 4,471 | 0 | $0 |
| 2026-05-20 | Samsara BioCapital, L.P. | ten percent owner | J | 66,906 | 0 | $0 |
| 2026-05-20 | Samsara BioCapital, L.P. | ten percent owner | P | 244,300 | 4.83 | $1,179,969 |
| 2026-05-20 | Samsara BioCapital, L.P. | ten percent owner | J | 14,937 | 0 | $0 |
| 2026-05-20 | AKKARAJU SRINIVAS; Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC; Samsara Opportunity Fund, L.P.; Samsara Opportunity Fund GP, LLC | director | P | 244,300 | 4.83 | $1,179,969 |
| 2026-05-20 | AKKARAJU SRINIVAS; Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC; Samsara Opportunity Fund, L.P.; Samsara Opportunity Fund GP, LLC | director | J | 66,906 | 0 | $0 |
| 2026-05-20 | AKKARAJU SRINIVAS; Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC; Samsara Opportunity Fund, L.P.; Samsara Opportunity Fund GP, LLC | director | J | 14,937 | 0 | $0 |
| 2026-05-20 | AKKARAJU SRINIVAS; Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC; Samsara Opportunity Fund, L.P.; Samsara Opportunity Fund GP, LLC | director | J | 4,471 | 0 | $0 |
| 2026-03-20 | Hagen Brett R | officer | S | 1,915 | 6.72 | $12,869 |
| 2026-03-20 | Hagen Brett R | officer | S | 1,915 | 6.72 | $12,869 |
| 2025-12-22 | AKKARAJU SRINIVAS | director | A | 1,500,000 | 10 | $15,000,000 |
| 2025-12-22 | AKKARAJU SRINIVAS; Samsara Opportunity Fund, L.P.; Samsara Opportunity Fund GP, LLC | director | A | 1,500,000 | 10 | $15,000,000 |
| 2025-12-18 | Samsara Opportunity Fund, L.P. | ten percent owner | P | 479,847 | 10.42 | $5,000,006 |
| 2025-12-18 | AKKARAJU SRINIVAS; Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC; Samsara Opportunity Fund, L.P.; Samsara Opportunity Fund GP, LLC | director | P | 479,847 | 10.42 | $5,000,006 |
| 2025-03-26 | Hagen Brett R | officer | S | 907 | 8.97 | $8,136 |
| 2025-03-26 | Hagen Brett R | officer | S | 907 | 8.97 | $8,135 |
| 2025-03-18 | Ferrara Napoleone | director | A | 504,000 | — | — |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT | director | A | 100,800 | — | — |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT | director | A | 252,000 | — | — |
| 2025-03-18 | Feinsod Matthew | officer | A | 4,030 | — | — |
| 2025-03-18 | AKKARAJU SRINIVAS | director | A | 11,444,503 | — | — |
| 2025-03-18 | Ferrara Napoleone | director | A | 504,000 | — | — |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT | director | A | 252,000 | — | — |
| 2025-03-18 | PATEL SAMIR CHANDRAKANT | director | A | 100,800 | — | — |
| 2025-03-18 | Feinsod Matthew | officer | A | 4,030 | — | — |
| 2025-03-18 | AKKARAJU SRINIVAS | director | A | 11,444,503 | — | — |
| 2025-02-21 | Sinha Vikas | director | S | 303 | 10.08 | $3,054 |
| 2025-02-21 | Hagen Brett R | officer | S | 96 | 10.08 | $968 |
| 2025-02-21 | Miller Edward | officer | S | 106 | 10.08 | $1,068 |
| 2025-02-21 | Sinha Vikas | director | S | 303 | 10.08 | $3,053 |
| 2025-02-21 | Hagen Brett R | officer | S | 96 | 10.08 | $967 |
| 2025-02-21 | Miller Edward | officer | S | 106 | 10.08 | $1,068 |
| 2025-01-23 | Miller Edward | officer | S | 47 | 9.45 | $444 |
| 2025-01-23 | Miller Edward | officer | S | 5 | 9.94 | $50 |
| 2025-01-23 | Hagen Brett R | officer | S | 4 | 9.94 | $40 |
| 2025-01-23 | Hagen Brett R | officer | S | 32 | 9.45 | $302 |
| 2025-01-23 | Sinha Vikas | director | S | 13 | 9.94 | $129 |
| 2025-01-23 | Sinha Vikas | director | S | 116 | 9.45 | $1,096 |
| 2025-01-23 | Miller Edward | officer | S | 47 | 9.45 | $444 |
| 2025-01-23 | Miller Edward | officer | S | 5 | 9.94 | $50 |
| 2025-01-23 | Hagen Brett R | officer | S | 32 | 9.45 | $303 |
| 2025-01-23 | Hagen Brett R | officer | S | 4 | 9.94 | $40 |
| 2025-01-23 | Sinha Vikas | director | S | 116 | 9.45 | $1,097 |
| 2025-01-23 | Sinha Vikas | director | S | 13 | 9.94 | $129 |
| 2025-01-10 | Miller Edward | officer | S | 409 | 0.44 | $180 |
| 2025-01-10 | Hagen Brett R | officer | S | 332 | 0.44 | $146 |
| 2025-01-10 | Sinha Vikas | director | S | 979 | 0.44 | $431 |
| 2025-01-10 | Miller Edward | officer | S | 409 | 0.44 | $180 |
| 2025-01-10 | Hagen Brett R | officer | S | 332 | 0.44 | $146 |
| 2025-01-10 | Sinha Vikas | director | S | 979 | 0.44 | $431 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.